Education
آخرین اخبار
Archive
Aug 24 2026
Achieving Normal Thyroid Function Before Pregnancy The Key to Reducing Maternal and Fetal Complications by Up to 70%
At the Weekly Conference of the Endocrinology and Metabolism Research Institute, the latest clinical guidelines of the American Thyroid Association (ATA) on the management of hyperthyroidism during pregnancy were reviewed. According to these guidelines, achieving euthyroidism (normal thyroid function) before conception is the cornerstone for reducing maternal and fetal complications. It was also emphasized that propylthiouracil (PTU) is the preferred treatment during the first trimester due to its lower risk of congenital malformations, and that measurement of TRAb/TSI antibodies plays a pivotal role in predicting disease relapse and monitoring fetal thyrotoxicosis.
Aug 18 2026
From Heart to Liver: Novel Diabetes Drugs Offer Dual Wings of Protection for High-Risk Patients
At the weekly Journal Club of the Endocrinology and Metabolism Research Institute, a comprehensive meta-analysis encompassing over 5.3 million diabetic patients was reviewed. The findings, presented in a PDF file, demonstrate that GLP-1 receptor agonists (GLP-1 RAs) and SGLT-2 inhibitors not only improve glycemic control and cardiovascular outcomes but also significantly reduce the risk of hepatocellular carcinoma (HCC) and non-HCC liver-related events. In contrast, DPP-4 inhibitors were associated with an increased risk of non-HCC liver-related complications. The session was well-received by faculty members and students alike.
Aug 5 2026
Three Complex Cases of Papillary Thyroid Cancer Discussed at the Monthly Thyroid Conference of the Research Institute
The monthly Thyroid Conference of the Endocrine Research Institute was held on Monday, August 5, 2026, featuring three challenging clinical cases of patients with Papillary Thyroid Cancer (PTC) with pulmonary metastases and recurrent disease, presented by Dr. Naghme Habibi, an endocrinology subspecialist. The session covered the latest diagnostic and therapeutic approaches, including radioactive iodine therapy, re-operation, targeted therapies such as Lenvatinib, and the importance of a multidisciplinary approach in managing these conditions.
Jul 29 2026
Monthly Pituitary Meeting Held at the Endocrinology Research Institute with Focus on Resistant Tumors and Diagnostic Challenges
The Monthly Pituitary Meeting of the Endocrinology and Metabolism Research Institute was held on Monday, July 27, 2026, with the attendance of faculty members, students, and specialists in pathology, radiology, and nuclear medicine. At this session, Dr. Zahra Noori, an endocrinology and metabolism subspecialist, presented three complex clinical cases including resistant prolactinoma, silent corticotroph adenoma, and pituitary incidentaloma, and elaborated on the latest international guidelines from leading global societies for managing these conditions.
Jul 28 2026
Impact of Pregnancy on the Progression of Papillary Thyroid Microcarcinoma: Is Active Surveillance Still a Safe Strategy?
A retrospective medical record review revealed that pregnancy may cause transient acceleration in the growth of papillary thyroid microcarcinoma (PTMC); however, these changes are mostly self‑limited, with tumor growth slowing or stabilizing after delivery. According to the findings presented at the Endocrine Research Institute's weekly Journal Club, Active Surveillance remains a safe and practical management approach for patients of reproductive age, with only a limited number of cases requiring delayed surgery postpartum.
اطلاعیه ها
Archive
Digital library Sources
Research Centers